Ardent Health Inc

Ardent Health Inc(ARDT)股票分析

$12.120

+0.446 (+3.68%)收盤時

Loading chart…
最高
12.130
開盤
11.840
成交量加權均價
12.03
成交量
343.08K
市值
—
最低
11.840
成交金額
4.13M
企業價值/稅息折舊攤銷前利潤(TTM)
8.15

Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.

AI 分析 of Ardent Health Inc (ARDT)

買進

Ardent Health Partners Inc is a good buy right now due to its current price of $11.95, which is below the average analyst price target of $13.67, indicating potential upside. Additionally, the forward P/E ratio of 9.50 suggests the stock is undervalued compared to its earnings potential. However, the main risk is the recent EPS miss of 29.41%, which could affect investor confidence.

估值指標

Ardent Health Inc(ARDT)目前預期本益比為 9.50,5 年平均預期本益比為 8.49。

預期本益比

合理
5 年均值 P/E
8.49
目前P/E
9.50
高估
10.18
低估
6.81

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
6.96
目前EV/EBITDA
8.15
高估
8.46
低估
5.45

預期股價營收比

合理
5 年均值 P/S
0.28
目前P/S
0.25
高估
0.37
低估
0.20

持有 ARDT 的大戶

G

GoldenTree Asset Management LP

+ 持有ARDT

-5.28%

3個月報酬率

事件時間軸

2026-09-29 (ET)

16:30:00

University of Kansas Health System Acquires St. Francis Campus

2026-09-02 (ET)

08:30:00

Ardent Health Expands Medical Services with UT Health East Texas Partnership

2026-08-04 (ET)

16:30:00

Company Confirms FY26 Revenue Outlook of $6.4B to $6.7B

16:30:00

Ardent Health Reports Q2 Revenue of $1.62B

2026-06-03 (ET)

09:40:00

Morgan Stanley Maintains Equal Weight Rating on Ardent Health with $12 Price Target

資訊

ARDT 常見問題 —— 由 Alphio AI 解答

Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings. It operates in the Healthcare sector.

Ardent Health Partners Inc is a good buy right now due to its current price of $11.95, which is below the average analyst price target of $13.67, indicating potential upside. Additionally, the forward P/E ratio of 9.50 suggests the stock is undervalued compared to its earnings potential. However, the main risk is the recent EPS miss of 29.41%, which could affect investor confidence.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易